Extract from ANSA article dated 01/02/2023 (ANSA) – PERUGIA, February 1 – The University of Perugia and the Diabetes Research Foundation Ets (Drf), affiliated with Confindustria Perugia and chaired by Prof. Riccardo Calafiore, have signed an articulated memorandum of understanding, lasting for five years, renewable, approved by the academic Senate of the University and by …
University of Perugia – Diabetes Research Foundation Read More »
INTERNATIONAL CONGRESS ON THE NEW FRONTIERS OF RESEARCH ON CELLULAR AND MOLECULAR THERAPY FOR TYPE 1 DIABETES MELLITUS: “STEM CELLS-DERIVED BETA CELLS”. BOSTON, USA. Riccardo Calafiore, Diabetes Research Foundation ETS and University of Perugia At the end of April last year, 2023, in Boston (USA), after the dark years of COVID, the World Congress on …
INTERNATIONAL CONGRESS “STEM CELLS-DERIVED BETA CELLS”. BOSTON, USA 24-25 April 2023. Read More »
WORLD CONGRESS OF THE THREE UNITED SCIENTIFIC SOCIETIES IPITA (International Pancreas and Islet Transplantation Association), IXA (International Xenotransplantation Association), and CTRMS (Cell Transplantation and Regenerative Medicine Society) ON THE NEW FRONTIERS OF RESEARCH ON CELLULAR AND MOLECULAR THERAPY FOR TYPE 1 DIABETES MELLITUS AND OTHER CHRONIC DISEASES, SAN DIEGO, U.S.A., October 26-29, 2023. Just a …
The oldest approach to the definitive treatment of type 1 diabetes mellitus (T1D), instead of the classic intensive insulin therapy, since 1982, has been pancreatic islet transplantation, extracted from the pancreas of human donors and transplanted into patients with the disease, under pharmacological immunosuppression of the recipients to avoid immune rejection, or as done first …
NEWS ON CELLULAR THERAPY FOR TYPE 1 DIABETES MELLITUS Read More »
